Ma Xiaoying

  • Director of the Oncology Department at St. Stamford Modern Cancer Hospital Guangzhou
  • Associate Chief Physician
  • Over 20 years of clinical experience in oncology
Consult Now

Professional Memberships

  • Member of the Specialized Committee on Medical Oncology, Chinese Anti-Cancer Association (CACA)
  • Member of the Specialized Committee of Tumor Endoscopy

Areas of Expertise

Dr. Ma specializes in the diagnosis and treatment of a wide range of malignant tumors, particularly:

Cancer Types

  • Digestive tract cancers
  • Breast Cancer
  • Lung Cancer
  • Gynecological cancers
  • Genitourinary cancers

Treatment Approaches

  • Chemotherapy
  • Endocrine therapy
  • Molecular targeted therapy
  • Immunotherapy
  • Integrated treatment for advanced and refractory cancers

Minimally Invasive Techniques

Dr. Ma is highly experienced in advanced minimally invasive cancer therapies, including:

  • Interventional therapy
  • Radioactive seed implantation
  • Cryotherapy
  • Nanoknife technology

Clinical Philosophy

Dr. Ma advocates an integrative treatment approach that combines effective tumor control with the preservation of patients’ quality of life. She emphasizes precision minimally invasive therapies designed to reduce treatment-related discomfort, improve recovery, and prolong survival, especially for patients who are not suitable candidates for conventional surgery.

Academic Contributions

Dr. Ma has published multiple academic papers in professional medical journals, with research focusing on:

  • Argon-helium cryoablation combined with chemotherapy for liver metastases from colorectal cancer
  • Management of immunotherapy-related side effects, including SJS/TEN caused by PD-1 inhibitors
  • Safety and short-term efficacy of combined therapies for esophageal cancer involving PD-1 inhibitors and targeted drugs

International Experience

Dr. Ma has treated more than 5,000 patients from Southeast Asia and actively participates in international medical collaborations. She is involved in cross-border academic and clinical exchanges with healthcare institutions in:

  • Thailand
  • Singapore
  • Vietnam
  • Malaysia
  • Indonesia

Through these collaborations, she helps promote and share China’s minimally invasive cancer treatment standards and clinical protocols internationally.

Start Your Treatment Journey Today

Get expert guidance and hospital recommendation tailored to your needs.
Start Your Treatment Plan